We are live on ! Find out more
HS

HighVista Strategies Portfolio holdings

AUM $362M
1-Year Est. Return 230.96%
This Fund
S&P 500
This Quarter Est. Return
+24.92%
1 Year Est. Return
+230.96%
3 Year Est. Return
+518.4%
5 Year Est. Return
+644.94%
10 Year Est. Return
+2,223.31%
AUM
$121M
AUM Growth
+$12.8M
Cap. Flow
-$3.03M
Cap. Flow %
-2.51%
Top 10 Hldgs %
72.03%
Holding
125
New
60
Increased
12
Reduced
11
Closed
25

Top Buys

Rank Stock Value
1
WTW icon
Willis Towers Watson
WTW
+$3.94M
2
TECD
Tech Data Corp
TECD
+$3.53M
3
CZR
Caesars Entertainment Corporation
CZR
+$3.46M
4
TIF
Tiffany & Co.
TIF
+$3.28M
5
LOGM
LogMein, Inc.
LOGM
+$2.89M

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$19.3M
2
CY
Cypress Semiconductor
CY
+$6.27M
3
S
Sprint Corporation
S
+$5.7M
4
RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
+$3.04M
5
MLNX
Mellanox Technologies, Ltd.
MLNX
+$2.79M

Sector Composition

Rank Sector Weight
1 Technology 43.2%
2 Healthcare 20.87%
3 Financials 13.46%
4 Consumer Discretionary 9.87%
5 Communication Services 0.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JNCE
76
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$104K 0.09%
15,000
+4,300
+40% +$23.2K
AFMD
77
DELISTED
Affimed
AFMD
$97K 0.08%
2,100
-1,270
-38% -$35.3K
MNKD icon
78
MannKind Corp
MNKD
$1.24B
$85K 0.07%
48,600
– –
PVLA
79
Palvella Therapeutics
PVLA
$2.24B
$83K 0.07%
335
+101
+43% +$23.6K
RVLP
80
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
$79K 0.07%
+11,800
New +$57.7K
RBBN icon
81
Ribbon Communications
RBBN
$358M
$77K 0.06%
19,700
-5,900
-23% -$21.4K
WSR
82
DELISTED
Whitestone REIT
WSR
$75K 0.06%
+10,300
New +$65.5K
RIGL icon
83
Rigel Pharmaceuticals
RIGL
$772M
$74K 0.06%
4,020
+1,450
+56% +$26.1K
ATEN icon
84
A10 Networks
ATEN
$1.97B
$73K 0.06%
10,700
– –
CPRX
85
DELISTED
Catalyst Pharmaceutical
CPRX
$73K 0.06%
15,800
– –
VKTX icon
86
Viking Therapeutics
VKTX
$3.96B
$73K 0.06%
10,100
– –
RYZ
87
Ryerson Holding Corp
RYZ
$1.46B
$70K 0.06%
+12,400
New +$61.3K
CDMO
88
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$68K 0.06%
10,300
– –
AGEN
89
Agenus
AGEN
$298M
$64K 0.05%
825
– –
MNOV icon
90
MediciNova
MNOV
$65M
$63K 0.05%
11,700
– –
ARAY icon
91
Accuray
ARAY
$35.7M
$57K 0.05%
28,300
+13,400
+90% +$27.9K
EPM icon
92
Evolution Petroleum
EPM
$135M
$55K 0.05%
19,800
+7,000
+55% +$18.8K
HROW icon
93
Harrow
HROW
$1.47B
$54K 0.04%
10,300
– –
ATHX
94
DELISTED
Athersys, Inc. Common Stock
ATHX
$52K 0.04%
752
-1,352
-64% -$94K
RLGT icon
95
Radiant Logistics
RLGT
$390M
$51K 0.04%
12,900
– –
OSG
96
DELISTED
Overseas Shipholding Group Inc.
OSG
$49K 0.04%
26,400
-8,600
-25% -$19.1K
BDSI
97
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$47K 0.04%
10,800
– –
SACH
98
Sachem Capital Corp
SACH
$39.1M
$37K 0.03%
12,500
– –
PDLI
99
DELISTED
PDL BioPharma, Inc.
PDLI
$37K 0.03%
12,700
-10,200
-45% -$32.3K
DHX icon
100
DHI Group
DHX
$162M
$32K 0.03%
15,100
-6,600
-30% -$17K
1 2 3
4
5

Similar funds

SIAG
Safeguard Investment Advisory Group Corona, California $362M AUM 20.96% 1-Year Est. Return
MS
Millington Securities Red Bank, New Jersey $362M AUM
WTFG
Wood Tarver Financial Group Boise, Idaho $362M AUM 14.75% 1-Year Est. Return
A6
Anchor @ 65 Singapore $362M AUM 20.02% 1-Year Est. Return
PI
Pennant Investors Summit, New Jersey $361M AUM 134.26% 1-Year Est. Return
ACM
Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return
BCC
Bridge City Capital Lake Oswego, Oregon $361M AUM 38.29% 1-Year Est. Return
PPG
Peak Planning Group Centennial, Colorado $361M AUM 22.01% 1-Year Est. Return

HighVista Strategies's Q2 2020 Portfolio in Review

As of Q2 2020, HighVista Strategies held 125 positions worth $121M, up 12% from $108M the previous quarter. Its ten largest holdings account for 72% of the portfolio.

HighVista Strategies's Q2 2020 filing shows 60 new, 12 increased, 11 reduced and 25 closed positions. Its largest new stake was Caesars Entertainment Corporation: 342,418 shares worth $4.15M. The largest sale was Allergan plc, an estimated $19.3M.

By sector, the portfolio is most concentrated in Technology at 43% of assets, up from 40% a quarter earlier, followed by Healthcare and Financials.

  • HighVista Strategies's largest Q2 2020 buy was Caesars Entertainment Corporation: 342,418 shares worth $4.15M.
  • HighVista Strategies added most to Willis Towers Watson in Q2 2020, an estimated $3.94M increase.
  • HighVista Strategies's biggest Q2 2020 reduction was Silvergate Capital Corporation, cutting an estimated $2.58M.
  • HighVista Strategies fully exited Allergan plc in Q2 2020, selling an estimated $19.3M.
  • HighVista Strategies's ten largest holdings make up 72% of its $121M portfolio in Q2 2020.
  • HighVista Strategies opened 60 new positions and closed 25 in Q2 2020.
  • HighVista Strategies's portfolio value rose 12% quarter-over-quarter to $121M.

Based on HighVista Strategies's 13F filing for Q2 2020, filed 14 Aug 2020.